ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,276 Cr | ₹1,716 Cr | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,276 Cr |
| Mar2025 | ₹1,716 Cr |
| Mar2024 | ₹1,296 Cr |
| Mar2023 | ₹1,003 Cr |
| Mar2022 | ₹806 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,276 Cr | 32.59 | |
| Mar2025 | ₹1,716 Cr | 32.48 | |
| Mar2024 | ₹1,296 Cr | 29.17 | |
| Mar2023 | ₹1,003 Cr | 24.50 | |
| Mar2022 | ₹806 Cr | - | |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹17,765.6 Cr | -1.6% | -12.2% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -1.6% |
-12.2% |
-15.5% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses